Karen Russo Since the biosimiliars market is still in its infancy stage, biopharmaceutical companies that are attempting to enter the space are encountering a variety of distinct challenges. The global regulations not only remain complicated, but they also continue to evolve and differ across certain regions...
Karen Russo From the newest medicines being used to fight rare disease to the latest innovative digital solutions that are helping to progress the biopharma industry, here were some of the up-and-coming trends that were discussed at World Orphan Drug Congress 2017. 1. Orphan Drugs - Since...
Karen Russo Desde los medicamentos más nuevos que se usan para combatir las enfermedades poco usuales, hasta las últimas soluciones digitales innovadoras que están ayudando a que avance la industria biofarmacéutica, aquí están incluidas algunas de las tendencias emergentes que se discutieron en el Congreso Mundial...
By Matt Craven 2018, the year of acquiring the best talent will once again be our primary focus. As always, talent acquisition will be on the hot seat everywhere. Locate, identify, qualify, engage and secure the top performers from the competition and do it faster than ever before. Here to...